Shelley Macintyre, CEO of Brands & Licensing at BBC Studios, sits down with SEG3 for this episode, exploring what it really takes to turn a hit show into a lasting franchise, without letting the brand get ahead of what fans will accept. With a career spanning Unilever, Coca-Cola and gin distillery SipSmith before BBC Studios, Shelley reveals how her team takes IP "from show to shelf," building storytelling around franchises like Bluey and Doctor Who so it can grow from screen into gaming, retail and live experiences. Shelley also explores how BBC Studios segments audiences by age and interest when building out from the core DNA of its IP. She goes into what early signals tell them an IP is ready to stretch, and how her team balances giving fans room to create with protecting brand health. So tune in for more on architecting IP for longevity, the metrics that can truly predict a franchise breakout, and a candid look at how AI fits into the future of fan engagement, loyalty, and trust.
0:00 – Who is Shelley Macintyre, and what does BBC Studios' Brands & Licensing division actually do?
1:10 – What does "show to shelf" mean in practice?
3:00 – How did a career at Unilever, Coca-Cola, and SipSmith prepare Shelley to build entertainment franchises?
12:10 – With such a wide catalogue of IP, how does BBC Studios decide what fits where?
12:45 – What's the three-step journey from cultural relevance to fan demand to commercial conversion?
15:00 – What makes Bluey's storytelling work for toddlers and their exhausted parents at the same time?
18:00 – How does a 60-year-old IP like Doctor Who stay relevant to new fans and nostalgic ones alike?
21:25 – What does it mean for a brand to have "permission" to stretch into new territory?
26:20 – What were the earliest signals that Bluey was becoming a global franchise, not just a hit show?
30:00 – How does BBC Studios think about fan-made content it doesn't control?
34:10 – Beyond sales, what actually signals a franchise is healthy?
36:50 – How different is the platform strategy for Doctor Who's core fans versus Bluey's stretch audiences?
40:35 – How do you localise a global franchise like Bluey without losing what makes it "Bluey"?
43:45 – With the Bluey movie landing in 2027, how do you keep a franchise from becoming overexposed?
47:55 – What are the first questions Shelley asks when a new IP shows franchise potential?
53:20 – What can traditional media learn from creators building their own IP — and what can creators learn back?
59:00 – Where is Shelley least confident the industry is getting it right?